Trial Profile
A study to assess the volumetric bone mineral content changes by 3D-DXA after two years of denosumab treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 24 Aug 2015 New trial record